Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

New Dystonia Drug Candidates Discovered

Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases.